Estrem Paul 4
4 · MELINTA THERAPEUTICS, INC. /NEW/ · Filed Jun 14, 2018
Insider Transaction Report
Form 4
Estrem Paul
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-06-12+76,000→ 76,000 totalExercise: $7.45Exp: 2028-04-20→ Common Stock (76,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the compensation committee of the Company's board of directors on April 20, 2018, subject to stockholder approval of an amendment to the stock option plan under which the option was granted. The Company's stockholders approved the plan amendment on June 12, 2018.
- [F2]One-quarter of the options will vest and become exercisable on April 20, 2019 and the remainder will vest and become exercisable in substantially equal monthly installments during the three year period commencing on April 20, 2019.